Webcasts Event RSS
Upcoming Events Past Events
Barclays Global Healthcare Conference
March 12, 2019
View the live Webcast
Cowen 39th Annual Health Care Conference
March 11, 2019
View the live Webcast
Halozyme to Host Fourth Quarter 2018 Financial Results Conference Call
February 21, 2019
View the live Webcast

Investor Materials

Thumb Date Download
July 20, 2018 Corporate Presentation 1.06 MB
December 31, 2017 2017 Annual Report 3.18 MB
July 24, 2016 2016 Annual Report 4.75 MB
July 23, 2016 2015 Annual Report 5.24 MB
July 21, 2016 2014 Annual Report 2.13 MB

Recent News

Date Title Press Release RSS
Halozyme To Participate In Upcoming Investor Conferences 03/04/19
Halozyme Announces FDA Approval Of Herceptin Hylecta™ 02/28/19
Halozyme Reports Fourth Quarter And Full-Year 2018 Results 02/21/19
Locke, K., et al. ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase PH20; Drug Delivery; 2019 02/11/19
See More

Stock Quote

HALO (NASDAQ) $15.97 -0.39 -2.38% Volume: 1,062,740 Pricing delayed 20 minutes April 18, 2019

Investor Contacts

Al Kildani
Vice President, Investor Relations
& Corporate Communications
Phone: 858-704-8122
Email: akildani@halozyme.com
media@halozyme.com
ir@halozyme.com

Useful Links

Contact Info


Office:

Halozyme
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: 858.794.8889
info@halozyme.com

Recent News

March 4, 2019 Halozyme To Participate In Upcoming Investor Conferences
February 28, 2019 Halozyme Announces FDA Approval Of Herceptin Hylecta™
February 21, 2019 Halozyme Reports Fourth Quarter And Full-Year 2018 Results
Copyright © 2015-2017 . Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.
Powered By Q4 Inc. 5.19.0.1

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok